EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Recombinant Human KAI1/CD82 Attenuates Glucocorticoid-Induced Muscle Atrophy by Promoting Myogenic Differentiation

Dong Hwan Kim iD, Hyesook Lee iD, Jung-Hwa Han iD, Yun Jeong Kang, Roo Gam Jeong, Jin Hur, Hyun Sik Gong

International Journal of Molecular Sciences · 11.03.2026 · 27 (6) · 2555

DOI: 10.3390/ijms27062555 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.03.2026. Verfasst von Dong Hwan Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Sindorim Seoul Orthopedic Clinic, Seoul 08210, Republic of Korea. Hauptthemen laut MEDLINE: Kangai-1 Protein, Cell Differentiation, Muscular Atrophy, Glucocorticoids. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korean Fund for Regenerative Medicine (KFRM) grant funded by the Korea government, 2-Year Research Grant of Pusan National University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcopenia and glucocorticoid-induced myopathy are significant forms of muscle atrophy that pose considerable public health challenges. In this regard, preventing muscle atrophy is crucial for enhancing quality of life and increasing life expectancy. In this study, we investigated the effect of recombinant human KAI1 (rhKAI1) on myogenic differentiation and its protective effect against dexamethasone-induced muscle atrophy. rhKAI1 enhanced myogenic differentiation in both murine C2C12 myoblasts and primary human endometrial stromal cells, as evidenced by upregulation of myogenic regulatory factors and increased myotube formation. These effects were accompanied by increased phosphorylation of Akt and AMPK. In a dexamethasone (Dex)-induced atrophy model, rhKAI1 increased myotube diameter, restored MyHC expression, and reduced the expression of the E3 ligase atrogin-1, accompanied by increased phosphorylation of Akt and AMPK. In addition, rhKAI1 administration improved Dex-induced functional impairment in mice, as reflected by increased grip strength and improved rotarod performance. Molecular analyses further showed that rhKAI1 modulated Dex-induced fiber-type-related gene expression by restoring MYH7 (type I) and reducing MYH4 (type IIb) expression. Collectively, our findings demonstrate that rhKAI1 promotes myogenic differentiation and alleviates several functional and molecular features associated with glucocorticoid-induced muscle deterioration. These results support the potential of rhKAI1 as a candidate molecule for further investigation in steroid-induced muscle dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kangai-1 ProteinCell DifferentiationMuscular AtrophyGlucocorticoidsRecombinant ProteinsMuscle DevelopmentAnimalsHumansMiceDexamethasoneMyoblastsFemaleCell LineMuscle Fibers, SkeletalProto-Oncogene Proteins c-aktPhosphorylation

Stichwörter der Autor:innen

dexamethasonemuscle atrophymyogenic differentiationrecombinant human KAI1 (rhKAI1)

Substanzen

Kangai-1 ProteinDexamethasoneGlucocorticoidsRecombinant ProteinsCD82 protein, humanProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Sindorim Seoul Orthopedic Clinic, Seoul 08210, Republic of Korea.
  • Department of Convergence Medicine, Pusan National University School of Medicine, Yangsan 50612, Republic of Korea.
  • R&D Center, Simplycarebio Co., Ltd., Room 607, 88 Somang-gil, Juchon-myeon, Gimhae-si 06125, Republic of Korea.
  • Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 50612, Republic of Korea.
  • PNU GRAND Convergence Medical Science Education Research Center, Pusan National University School of Medicine, Yangsan 50612, Republic of Korea.
  • Department of Orthopedic Surgery, Seoul National University Bundang Hospital, Seongnam-si 13620, Republic of Korea.

ORCID-Profile: Dong Hwan Kim, Hyesook Lee, Jung-Hwa Han

Förderung

  • Korean Fund for Regenerative Medicine (KFRM) grant funded by the Korea government
  • 2-Year Research Grant of Pusan National University

Zitieren

APA

Kim, D. H., Lee, H., Han, J. H., Kang, Y. J., Jeong, R. G., Hur, J., & Gong, H. S. (2026). Recombinant Human KAI1/CD82 Attenuates Glucocorticoid-Induced Muscle Atrophy by Promoting Myogenic Differentiation. International Journal of Molecular Sciences, 27(6), 2555. https://doi.org/10.3390/ijms27062555

Vancouver

Kim DH, Lee H, Han JH, Kang YJ, Jeong RG, Hur J, et al. Recombinant Human KAI1/CD82 Attenuates Glucocorticoid-Induced Muscle Atrophy by Promoting Myogenic Differentiation. International Journal of Molecular Sciences. 2026;27(6):2555. doi:10.3390/ijms27062555

BibTeX
@article{Kim2026,
  author = {Kim, Dong Hwan and Lee, Hyesook and Han, Jung-Hwa and Kang, Yun Jeong and Jeong, Roo Gam and Hur, Jin and Gong, Hyun Sik},
  title = {Recombinant Human KAI1/CD82 Attenuates Glucocorticoid-Induced Muscle Atrophy by Promoting Myogenic Differentiation},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {6},
  pages = {2555},
  doi = {10.3390/ijms27062555}
}
Kostenlos starten →